Tong Ren Tang Chinese Medicine (03613.HK): “Angelica Blood Supplement Granules [Tong Ren Tang]” approved for sale in Hong Kong
Gelonghui, April 30, 丨 Tong Ren Tang Chinese Medicine (03613.HK) announced that the company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Angelica Supplementation Granules [Tong Ren Tang]” in Hong Kong. The relevant information notice is as follows: Drug Name: Angelica Blood Supplementation Granules [Tong Ren Tang]; Registered Holder and Address: Beijing Tong Ren Tang Sinopharm Co., Ltd., No. 3, Da Jing Street, Tai Po Industrial Estate, New Territories, Hong Kong; registration number: HKC-18604; certificate validity period: until April 25, 2029.” The main function of “Angelica Blood Supplementation Granules [Tong Ren Tang]”
現代中藥集團:2023年報
Tong Ren Tang Chinese Medicine (03613): Issued a certificate of registration for proprietary Chinese medicines
According to Zhitong Finance App, Tong Ren Tang Sinopharm (03613) issued an announcement. The company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration, which allows the sale of “Angelica Blood Supplementation Granules [Tong Ren Tang]” in Hong Kong.
Express News | Tong Ren Tang: Holding Sun Company obtained the Hong Kong Proprietary Chinese Medicine Registration Certificate for Angelica Blood Supplements
Tong Ren Tang's Q1 Profit Jumps 10%, Revenue Rises 2%
Beijing Tong Ren Tang Group's (SHA:600085) attributable net profit edged up 10% year over year in the first quarter to 575.9 million yuan from 523.4 million yuan a year earlier, the company said in a
Express News | Baiyun Mountain: Wang Laoji collaborates with KFC